Banner 3

The Featured Programme

PUBHealth operates through three integrated verticals, each with
distinct deliverables

Biotech  Therapeutics

Biotech & Therapeutics

Developing solutions for neglected and underserved conditions. Key initiatives include:
  • Snakebite Envenomation Solutions: A rapid point-of-care test (identifying krait/cobra/viper bites) and a region-specific polyvalent antivenom program.
  • Camelid Antibody (Nanobody) Platform: Stable single-domain antibodies for snakebite therapy, affordable autoimmune treatments, low-cost cancer diagnostics, bone-regeneration biologics, and more.
  • Human Hyperimmune Serum Production: Local manufacturing of pooled human plasma therapies (e.g. for rabies, Hepatitis B, tetanus, diphtheria).
  • Therapeutic Bacteriophage Platform (AMR): Custom phage cocktails against multi-drug-resistant Gram-negative infections.

Assistive Technology

Creating devices that restore independence. Deliverables include:
  • Third Eye System: A wearable AI assistant that describes the environment for blind users (camera+LiDAR + on-device AI).
  • Modular Prosthetic Arm: A rugged, low-cost myoelectric arm for amputees, with local fit and maintenance services.
Assistive Technology
Research Policy  Education

Research, Policy & Education

Generating knowledge outputs to support technologies. Outputs include:
  • Publications & Data: Clinical studies, engineering reports, epidemiological analyses (e.g. snakebite registries).
  • Policy Briefs & Roadmaps: Guidance documents (e.g. snakebite elimination roadmaps, technology integration guidelines).
  • Advocacy Materials: Educational brochures and briefs for stakeholders (e.g. injury prevention, disability rights).
Pubhealth
Scroll to Top